Sponsor or institution

Clinical trials and research at Institut Claudius Regaud

• 30Clinical trials
• 4Countries

Newest trials

All recruiting trials (30)

• Routine shallow-coverage Whole Genome Sequencing of Cervical Smears to See if Ovarian Cancer is Found Earlier

  Researchers test whether analyzing DNA from cervical smears with shallow whole-genome sequencing can help detect high-grade serous ovarian cancer early in patients undergoing treatment for this cancer.

  Recruiting Institut Claudius Regaud · Toulouse · NCT07821879

• Male Breast Cancer Predisposition Factor: Create a Control Group

  This study tests genetic and psychosocial data in men who are relatives of men with breast cancer but who themselves have no cancer history.

  Recruiting Institut Claudius Regaud · Toulouse · NCT07558343

• Biomarkers and immune responses in early-stage solid cancers treated with immunotherapy

  This study tests immune biomarkers in patients with early-stage solid cancers who are receiving immune checkpoint blockade before surgery.

  Recruiting Institut Claudius Regaud · Toulouse and 2 other locations · NCT07427186

• Atlas of cell organelles and protein patterns in breast cancer subtypes

  This project will collect tumor and blood samples from people with early or newly metastatic breast cancer to test how much fat accumulates in tiny cell structures (lipid droplets) and to map protein patterns across tumor subtypes.

  Recruiting Institut Claudius Regaud · Toulouse · NCT07233928

• Comparing blood levels of the free‑DXd payload from trastuzumab‑deruxtecan by BMI in people with advanced or metastatic breast cancer

  This study will test whether body mass index changes blood levels of the free‑DXd payload in adults with locally advanced or metastatic HER2‑low or HER2‑positive breast cancer who are receiving trastuzumab‑deruxtecan.

  Recruiting at 6 sites Phase 4 Institut Claudius Regaud · Angers and 9 other locations · NCT07195344

• Detecting double-positive (tumor marker/CD45+) cells in the blood of people with metastatic cancer

  This one-day study will test two blood-based methods to find double-positive tumor/CD45+ circulating cells in adults who are about to start treatment for various metastatic cancers.

  Recruiting Institut Claudius Regaud · Toulouse · NCT06967961

• Comparing blood PSMA-positive tumor cells with PSMA PET imaging and outcomes in prostate cancer

  This will test whether PSMA-positive circulating tumor cells in a blood sample match 18F-PSMA PET scan results and help predict outcomes for people with prostate cancer getting PSMA PET imaging.

  Recruiting Institut Claudius Regaud · Toulouse · NCT06917781

• Comparing methods to capture circulating tumor cells in metastatic breast or prostate cancer

  This one-day test will compare three blood-based methods (CellSearch®, Parsortix®, and SmartCatch®) to see which best finds circulating tumor cells in people with metastatic breast or prostate cancer before they start a new line of treatment.

  Recruiting Institut Claudius Regaud · Toulouse · NCT06904625

• Evaluating a blood test to predict treatment response in patients with intestinal neuroendocrine tumors

  This study is testing if a blood test can help predict how well a new treatment works for patients with advanced intestinal neuroendocrine tumors.

  Recruiting at 9 sites Institut Claudius Regaud · Angers and 9 other locations · NCT06876532

• Decentralized care pathway for cancer patients receiving oral treatment

  This study is testing a new way for cancer patients on oral chemotherapy to receive care at home from a nurse instead of going to the hospital, to see if it makes them happier and helps them stick to their treatment.

  Recruiting Institut Claudius Regaud · Toulouse · NCT06797037

• Hippocampal radiation dose and memory in children treated for brain tumors

  This project will test whether the amount of radiation the hippocampus receives is linked to later memory problems in children treated with brain irradiation.

  Recruiting at 10 sites Institut Claudius Regaud · Angers and 13 other locations · NCT06599879

• Detecting gene mutations in blood from ovarian cancer patients on PARP inhibitor therapy

  This study is testing if checking blood for specific gene changes in ovarian cancer patients on a treatment called Olaparib can help doctors catch problems early and improve their care.

  Recruiting at 6 sites Institut Claudius Regaud · Angers and 5 other locations · NCT06588322

• Onco-sexology program for laryngectomy patients and their partners

  This study is trying out a special program to see if it can help laryngectomy patients and their partners feel better about their intimate lives after surgery.

  Recruiting Institut Claudius Regaud · Toulouse · NCT06517355

• Investigating biomarkers in glioblastoma patients treated with TTFields

  This study is testing how well a new treatment called TTFields works for people with newly diagnosed glioblastoma by looking for signs in their blood and tumors that show if they respond to the treatment.

  Recruiting Institut Claudius Regaud · Toulouse · NCT06222138

• Evaluating radiation therapy for older patients with soft tissue sarcoma

  This study is testing a type of radiation therapy to see if it helps older patients with soft tissue sarcoma heal better after surgery.

  Recruiting at 11 sites Phase 2 Institut Claudius Regaud · Bordeaux and 10 other locations · NCT06022159

• Understanding the risks of blood disorders in families with DDX41 gene mutations

  This study is trying to see if people with a specific gene mutation in their family are at higher risk for blood disorders like leukemia and how this information can help their family members.

  Recruiting at 5 sites Institut Claudius Regaud · Bordeaux and 4 other locations · NCT06022016

• Characterizing predictive parameters of GATA2 gene mutation

  This study is trying to understand how the GATA2 gene mutation affects people over time by collecting blood and bone marrow samples from 250 patients with the mutation.

  Recruiting at 23 sites Institut Claudius Regaud · Angers and 23 other locations · NCT05983991

• Blocking TNF to Enhance Immune Response in Melanoma Treatment

  This study is testing if blocking a specific protein can help improve the immune response in melanoma patients who are not responding well to their current treatment.

  Recruiting Institut Claudius Regaud · Toulouse · NCT05867004

• New surgical procedure for reconstructing the oral cavity and oropharynx in cancer patients

  This study is testing a new surgical method using a special tissue flap to see if it can safely help cancer patients who need reconstruction in their mouth and throat areas.

  Recruiting at 2 sites Institut Claudius Regaud · Montpellier and 3 other locations · NCT05757817

• Surgery followed by tailored treatment for advanced cervical cancer

  This study is testing whether surgery followed by personalized treatment can help women with advanced cervical cancer live longer and healthier compared to standard treatment alone.

  Recruiting at 33 sites Phase 3 Institut Claudius Regaud · Ostrava and 36 other locations · NCT05581121

• Evaluating biomarkers for PARP inhibitor resistance in breast cancer patients with BRCA mutations

  This study is testing if certain DNA repair factors can help explain why some breast cancer patients with BRCA mutations don't respond to PARP inhibitors.

  Recruiting at 21 sites Institut Claudius Regaud · Bordeaux and 24 other locations · NCT05378204

• Video-assisted speech therapy for patients with ORL cancer

  This study tests if video calls with speech therapists can help patients with head and neck cancer improve their speaking and swallowing skills.

  Recruiting Institut Claudius Regaud · Toulouse · NCT04940000

• Evaluating the impact of alternative therapies on tamoxifen adherence in breast cancer patients

  This study is testing whether using alternative therapies helps breast cancer patients stick to their tamoxifen treatment better.

  Recruiting Institut Claudius Regaud · Toulouse · NCT04740697

• Pre-operative rehabilitation for patients with limb sarcoma

  This study is testing a pre-surgery rehab program to see if it helps people with limb sarcoma recover better and regain their independence after surgery.

  Recruiting Phase 2 Institut Claudius Regaud · Toulouse · NCT04515459

• Radiotherapy for bladder cancer patients with limited metastases after initial treatment

  This study is testing if adding local radiotherapy to standard care can help bladder cancer patients with a few remaining metastatic spots live longer after their initial treatment.

  Recruiting at 15 sites Phase 2 Institut Claudius Regaud · Albi and 19 other locations · NCT04428554

• Adding chemotherapy to surgery for high-risk localized soft tissue sarcoma

  This study is testing if adding chemotherapy to surgery can help people with high-risk localized soft tissue sarcoma live longer without their cancer spreading.

  Recruiting at 20 sites Phase 3 Institut Claudius Regaud · Besançon and 19 other locations · NCT04307277

• Characterizing rare soft tissue sarcomas

  This study is trying to learn more about rare types of soft tissue sarcomas by collecting detailed information from 400 patients to help improve treatment options.

  Recruiting at 16 sites Institut Claudius Regaud · Besançon and 19 other locations · NCT03967834

• Understanding how cancer cells evade the immune system

  This study is trying to understand how cancer cells hide from the immune system by looking at blood and tumor samples from 900 patients with different types of solid tumors.

  Recruiting at 3 sites Institut Claudius Regaud · Toulouse and 2 other locations · NCT03958240

• Identifying factors in platinum resistance for ovarian cancer

  This study is trying to find out why some people with ovarian cancer don’t respond to standard platinum chemotherapy, by collecting information and samples from patients receiving this treatment.

  Recruiting Institut Claudius Regaud · Toulouse · NCT03954171

• Monitoring immune responses and biomarkers in cancer immunotherapy

  This study is testing how well certain immune responses and markers in the blood can help predict how patients with advanced solid cancers respond to new immunotherapy treatments.

  Recruiting at 3 sites Institut Claudius Regaud · Toulouse and 2 other locations · NCT03514368

Quick answers

How many clinical trials run by Institut Claudius Regaud are recruiting right now?

30, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in France (30 trials), Czechia (1 trial), Italy (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 3: 2, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →